Top Injectable Manufacturer in Eswatini – Reliable Pharmaceutical Solutions
Last Updated: September 9, 2026
TL;DR: Eswatini is the market where our standing question stops working. We ask whether a country names the foreign regulators it leans on; Eswatini has not been operating a national registration system at all, so there is no decision for a foreign decision to be leaned into. The Ministry of Health's own 2021 policy says the country "is currently not actively registering medicines". What exists instead is a certificate test sitting on the import permit, and it is agency-agnostic: produce the product registration certificate from the regulator in the country of origin, whoever that regulator is.
Key Takeaways
There is no list, and no register either. We found no published Eswatini list of recognised foreign regulatory authorities and no instrument naming CDSCO, to recognise or to exclude it. The Ministry's 2012 import guideline requires product registration certificates for the medicines to be imported, "issued by the relevant authorities in the country of normal origin", plus batch analysis certificates. On its face an Indian certificate meets that description; we found no Eswatini statement confirming it in practice.
The Act exists; commencement could not be confirmed. The Medicines and Related Substances Control Act (Act 9 of 2016; the short-title clause reads "2015") provides for a Medicines Regulatory Authority, but section 1(2) brings it into force on a date appointed by the Minister in the Gazette — we found no commencement notice and could not access a searchable Gazette. The Authority's board was reported unveiled on 8 January 2026, with no register, no finalised regulations and no quality-control laboratory behind it.
The binding constraint is the importer, decisively. Imports must run through the Ministry or through authorised pharmaceutical importers registered with it; the criteria are suitable warehousing premises and suitably qualified pharmaceutical personnel, and the certificate names a supervising pharmacist. Permit validity shall not exceed six months, and no importation of medicines may be done by post.
The gate that actually bites is a donor rule, not an Eswatini rule. About 28% of current health expenditure was external money in 2023, and the Global Fund's Quality Assurance Policy requires WHO prequalification, an SRA, a WLA or ERP review for antiretroviral, anti-tuberculosis and antimalarial products — its ERP route requiring GMP verified by WHO-PQ, an SRA or WLA, or a PIC/S authority, which is where India's PIC/S non-membership tells.
Introduction: Why Eswatini Demands a Premium Injectable Manufacturer in Eswatini
Every market in this series opens by asking whether the country publishes a list of foreign regulatory authorities it will lean on, and whether India's CDSCO is among them. Eswatini is the first where the honest answer is that the question does not fit. The Ministry of Health's National Pharmacovigilance Policy of June 2021 states that the country "is currently not actively registering medicines", and that suppliers are registered as importers and issued an import certificate while "these products are not considered as being registered". There is no registration decision into which a foreign decision could be leaned.
What operates in its place is a documentary test at the border, and it is agency-agnostic. The 2012 import guideline asks for the product registration certificate issued by "the relevant authorities in the country of normal origin" — open-ended, with no list of acceptable authorities anywhere in it. The Ministry's own medicines database asks which authority registered a product without restricting which authorities count. So an Indian certificate is, on the published documents, the same kind of object as anyone else's. We found no statement confirming that in practice, and a serious injectable manufacturer in Eswatini does not upgrade a silence into a permission.
What Sets a World-Class Injectable Manufacturer in Eswatini Apart
Site rules and product rules must be kept apart: on the statute book both exist, and in practice neither operates as written. Part VI of the 2016 Act provides for manufacturer, wholesaler and import or export licences, issued on conditions relating to good manufacturing and distribution practices, valid for not more than three years. But the licensing subjects are defined by reference to premises licensed under the Pharmacy Act, 1929 — and the text of that Act we read registers chemists as persons and contains no premises-licensing provision we could identify. We found nothing creating a foreign-site licence or an overseas GMP inspection programme.
So a WHO-GMP certificate is commercially and donor-relevant here rather than legally operative. We found no Eswatini legal instrument that requires it, evaluates it, or confers status on it; it is in neither the 2012 guideline's document list nor the published tender advert — though the Instructions to Tenderers is not downloadable and we could not obtain it, so that is "not stated in the advert", never "not required". Nor is there a national quality-control laboratory: reporting in 2026 describes incoming stock checked by visual inspection.
Quality Systems Behind Every Injectable Supplied to Eswatini
With no national dossier standard published, the discipline has to come from the manufacturer's own systems and the channels that do impose one. We found no published Eswatini dossier-format requirement — section 24(2) of the Act defers the content of an application entirely to the Authority or to regulations, and we found no evidence regulations have been finalised — so CTD and ACTD are what a serious supplier brings, not what Eswatini demands. That means aseptic process simulation for the ISO Class 5 filling line, environmental monitoring, container-closure integrity, sterility and LAL endotoxin testing, and validated HPLC and GC methods, with ICH Q1A and Q1B stability behind them.
On stability, report the position rather than a number. We found no Eswatini-published stability guideline. A SADC annexure reproduced in Zambia's stability guideline, derived from a WHO table updated 1 February 2013, assigns Swaziland long-term conditions of 25 °C and 60% relative humidity — Climatic Zone II. Do not read that as a relaxation: a supplier covering neighbouring SADC markets would in practice generate 30 °C and 75% data, and be right to. Eswatini is a non-active ZaZiBoNa member, does not appear on WHO's ML3 or ML4 list, is not a PIC/S participating authority, and has not signed the African Medicines Agency Treaty.
Looking for a sterile injectable manufacturing partner? Talk to Farbe Firma about your market entry.
Why Farbe Firma is the Trusted Injectable Manufacturer in Eswatini for Global Buyers
Farbe Firma Pvt Ltd is a WHO-GMP certified sterile injectable manufacturer and CDMO based in Gujarat, India, filling under ISO Class 5 conditions and exporting to more than 30 countries. We hold no Eswatini registration, licence or accreditation and claim none. What we supply is what the published route asks for: the Indian product registration certificate, the batch certificate of analysis, full manufacturer particulars, and the product data the import permit needs. The rest sits with a locally authorised importer holding Ministry registration, compliant warehousing and a named supervising pharmacist.
Public tendering is a separate track, and the common assumption about it is wrong. Section 39 of the Public Procurement Act 2011 prohibits excluding a tenderer on grounds of nationality, and the national Standard Tender Document states that all countries are eligible and that the provider's nationality does not determine the goods' origin. A Swati agent is a price-preference lever, not an access gate: an unrepresented foreign bidder can be evaluated at up to 15% above its actual price, and partnering caps that at 7.5%. The barriers are physical, not legal — sealed paper bids to the Treasury Tender Box in Mbabane — and bidders must enclose a Manufacturer's Authorisation.
Three market facts, each with its basis. Roughly 28 cents in every health dollar was donor money in 2023, so a large slice of the medicines market is donor-procured rather than government-tendered — and for antiretroviral, TB and antimalarial products the Global Fund gate applies, which CDSCO's vaccines-only ML3 scope and India's PIC/S non-membership do not open. Population carries its basis: the 2017 census enumerated 1,093,238 and the World Bank estimate for 2025 is 1,256,174, so every per-capita figure rests on projection. And the bilateral ground is better than the paperwork suggests — about 2,000 Indians live in Eswatini, around 90% of them from Gujarat.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Does Eswatini accept Indian CDSCO product registration?
We found no Eswatini instrument that names CDSCO, to recognise or to exclude it. The published import guideline requires the product registration certificate issued by the authority in the country of origin, without naming which regulators qualify; on its face an Indian certificate meets that description. We found no statement confirming this in practice, and a Ministry communications officer has been quoted saying suppliers must source from accredited manufacturers, with orders from manufacturers not on the list rejected. We found no published list, criteria or statutory basis for that, and it rests on a single secondary source.
Who is Eswatini's medicines regulator today?
Regulatory functions have in practice been carried out by the Medicines Regulatory Unit within the Ministry of Health. The Act establishes a Medicines Regulatory Authority, whose board was reported unveiled on 8 January 2026 by two Eswatini outlets; we found no primary or official-government confirmation, and no evidence the Authority has begun registering medicines. Eswatini media use both "MRA" and "EMRA"; no primary source we found uses "EMRA". Do not confuse this with EMSA, the Eswatini Medical Supplies Agency, a supply-chain body and not a regulator.
Is a CPP or a GMP certificate required to supply Eswatini?
We found no published Eswatini requirement for either. The 2012 guideline's introduction stresses the WHO Certification Scheme, but the Certificate of a Pharmaceutical Product does not appear in its actual documentation requirements — what it requires is the country-of-origin registration certificate and batch analysis certificates. A GMP certificate is likewise absent from the document list and the published tender advert. Both statements are about what the published documents say; the Instructions to Tenderers could not be obtained, and regulations under section 72 could impose either.
Does a ZaZiBoNa approval let you sell in Eswatini?
No. ZaZiBoNa is a collaborative registration initiative that issues recommendations from joint assessment; its own site states those can be used to support registrations at country level. Registration remains a national act, and Eswatini is not currently registering medicines, so there is nothing for a recommendation to convert into. Eswatini is a non-active member — active status requires assessment and GMP inspection capacity. It may become relevant later; it is not a route into Eswatini today.
What can Farbe Firma actually do for a partner supplying Eswatini?
Manufacture, and supply the documents the route asks for. Farbe Firma is a WHO-GMP certified sterile injectable manufacturer and CDMO in Gujarat, India, filling under ISO Class 5 conditions and exporting to more than 30 countries. We prepare CTD and ACTD dossiers, provide the Indian registration certificate, batch certificates of analysis, WHO-format CPP and GMP certificate, and ICH Q1A and Q1B stability data. We work through a locally authorised importer, and we make no claim to be registered, listed or accredited in Eswatini.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments